903 related articles for article (PubMed ID: 36209270)
21. MicroRNAs May Serve as Emerging Molecular Biomarkers for Diagnosis and Prognostic Assessment or as Targets for Therapy in Gastric Cancer.
Mu YP; Sun WJ; Lu CW; Su XL
Asian Pac J Cancer Prev; 2015; 16(12):4813-20. PubMed ID: 26163596
[TBL] [Abstract][Full Text] [Related]
22. Early B-cell factors involve in the tumorigenesis and predict the overall survival of gastric cancer.
Wang Q; Liang J; Hu X; Gu S; Xu Q; Yan J
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34100918
[TBL] [Abstract][Full Text] [Related]
23. Novel Biomarkers of microRNAs in Gastric Cancer: An Overview from Diagnosis to Treatment.
Mirzajani E; Vahidi S; Norollahi SE; Samadani AA
Microrna; 2022; 11(1):12-24. PubMed ID: 35319404
[TBL] [Abstract][Full Text] [Related]
24. DDAH1 mediates gastric cancer cell invasion and metastasis via Wnt/β-catenin signaling pathway.
Ye J; Xu J; Li Y; Huang Q; Huang J; Wang J; Zhong W; Lin X; Chen W; Lin X
Mol Oncol; 2017 Sep; 11(9):1208-1224. PubMed ID: 28580735
[TBL] [Abstract][Full Text] [Related]
25. A novel treatment strategy for lapatinib resistance in a subset of HER2-amplified gastric cancer.
Ning G; Zhu Q; Kang W; Lee H; Maher L; Suh YS; Michaud M; Silva M; Kwon JY; Zhang C; Lee C
BMC Cancer; 2021 Aug; 21(1):923. PubMed ID: 34399705
[TBL] [Abstract][Full Text] [Related]
26. Circular RNA hsa_circ_0010882 promotes the progression of gastric cancer via regulation of the PI3K/Akt/mTOR signaling pathway.
Peng YK; Pu K; Su HX; Zhang J; Zheng Y; Ji R; Guo QH; Wang YP; Guan QL; Zhou YN
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1142-1151. PubMed ID: 32096170
[TBL] [Abstract][Full Text] [Related]
27. Exploring the role of molecular biomarkers as a potential weapon against gastric cancer: A review of the literature.
Matboli M; El-Nakeep S; Hossam N; Habieb A; Azazy AE; Ebrahim AE; Nagy Z; Abdel-Rahman O
World J Gastroenterol; 2016 Jul; 22(26):5896-908. PubMed ID: 27468184
[TBL] [Abstract][Full Text] [Related]
28. Natural products targeting signaling pathways associated with regulated cell death in gastric cancer: Recent advances and perspectives.
Hu Q; Li Z; Li Y; Deng X; Chen Y; Ma X; Zeng J; Zhao Y
Phytother Res; 2023 Jun; 37(6):2661-2692. PubMed ID: 37157181
[TBL] [Abstract][Full Text] [Related]
29. Updates on global epidemiology, risk and prognostic factors of gastric cancer.
Yang WJ; Zhao HP; Yu Y; Wang JH; Guo L; Liu JY; Pu J; Lv J
World J Gastroenterol; 2023 Apr; 29(16):2452-2468. PubMed ID: 37179585
[TBL] [Abstract][Full Text] [Related]
30. SKAP1 Is a Novel Biomarker and Therapeutic Target for Gastric Cancer: Evidence from Expression, Functional, and Bioinformatic Analyses.
Zhu L; Yu Q; Li Y; Zhang M; Peng Z; Wang S; Quan Z; Gao D
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511629
[TBL] [Abstract][Full Text] [Related]
31. The Multifaceted Role of Long Non-Coding RNA in Gastric Cancer: Current Status and Future Perspectives.
Li Y; Lu L; Wu X; Li Q; Zhao Y; Du F; Chen Y; Shen J; Xiao Z; Wu Z; Hu W; Cho CH; Li M
Int J Biol Sci; 2021; 17(11):2737-2755. PubMed ID: 34345204
[TBL] [Abstract][Full Text] [Related]
32. Review of recent molecular landscape knowledge of gastric cancer.
Shimizu D; Kanda M; Kodera Y
Histol Histopathol; 2018 Jan; 33(1):11-26. PubMed ID: 28447336
[TBL] [Abstract][Full Text] [Related]
33. miR-21 modulates cisplatin resistance of gastric cancer cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
Gu Y; Fei Z; Zhu R
Anticancer Drugs; 2020 Apr; 31(4):385-393. PubMed ID: 31913198
[TBL] [Abstract][Full Text] [Related]
34. Genomic Profiling of HER2-Positive Gastric Cancer: PI3K/Akt/mTOR Pathway as Predictor of Outcomes in HER2-Positive Advanced Gastric Cancer Treated with Trastuzumab.
Díaz-Serrano A; Angulo B; Dominguez C; Pazo-Cid R; Salud A; Jiménez-Fonseca P; Leon A; Galan MC; Alsina M; Rivera F; Plaza JC; Paz-Ares L; Lopez-Rios F; Gómez-Martín C
Oncologist; 2018 Sep; 23(9):1092-1102. PubMed ID: 29700210
[TBL] [Abstract][Full Text] [Related]
35. Gastric Cancer: Molecular Mechanisms, Novel Targets, and Immunotherapies: From Bench to Clinical Therapeutics.
Baccili Cury Megid T; Farooq AR; Wang X; Elimova E
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894443
[TBL] [Abstract][Full Text] [Related]
36. HER2+ Cancer Cell Dependence on PI3K vs. MAPK Signaling Axes Is Determined by Expression of EGFR, ERBB3 and CDKN1B.
Kirouac DC; Du J; Lahdenranta J; Onsum MD; Nielsen UB; Schoeberl B; McDonagh CF
PLoS Comput Biol; 2016 Apr; 12(4):e1004827. PubMed ID: 27035903
[TBL] [Abstract][Full Text] [Related]
37. Noggin is associated with a poor prognosis of gastric cancer by promoting the proliferation of gastric cancer cells via the upregulation of EGFR.
Sun Z; Gao X; Zabkiewicz C; Ruge F; Xie M; Cai S; Sun PH; Griffiths P; Pugh MR; Ji J; Jiang WG; Ye L
Int J Oncol; 2020 Sep; 57(3):813-824. PubMed ID: 32705152
[TBL] [Abstract][Full Text] [Related]
38. Heterogeneity in Gastric Cancer: From Pure Morphology to Molecular Classifications.
Gullo I; Carneiro F; Oliveira C; Almeida GM
Pathobiology; 2018; 85(1-2):50-63. PubMed ID: 28618420
[TBL] [Abstract][Full Text] [Related]
39. A novel proteomics-based clinical diagnostics technology identifies heterogeneity in activated signaling pathways in gastric cancers.
Lee J; Kim S; Kim P; Liu X; Lee T; Kim KM; Do IG; Park JO; Park SH; Jang J; Hoe N; Harvie G; Kuller A; Jain A; Meyer G; Leesman G; Park YS; Choi MG; Sohn TS; Bae JM; Lim HY; Singh S; Kang WK
PLoS One; 2013; 8(1):e54644. PubMed ID: 23372746
[TBL] [Abstract][Full Text] [Related]
40. Advances in Molecular Biomarkers for Gastric Cancer.
Zheng TH; Zhao JL; Guleng B
Crit Rev Eukaryot Gene Expr; 2015; 25(4):299-305. PubMed ID: 26559090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
